UroGen's Chief Medical Officer Sold $400,000 in Stock After a 191% Run
Mark Schoenberg's final disposition under a pre-established Rule 10b5-1 plan follows 191% annual returns, leaving him with 119,763 shares worth $4.82 million.
Read the full articleYou might also wanna read
Insider Sell: Richard Mccathron Sells 5,000 Shares of Hippo Holdings Inc (HIPO)
Related Stocks: HIPO
GuruFocus·3d ago
The Main Reason Behind Buying UnitedHealth Before July 16
UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, an
24/7 Wall St.·6d ago
Gemeinschaftsunternehmen mit Apollo: Latham und Linklaters beraten zu Bayer-Deal
Rechtsstreitigkeiten bei der US-Monsanto belasten seit Jahren die Bilanz von Bayer. Ein Deal mit dem Vermögensverwalter Apollo verschafft de
Legal Tribune Online·2d ago
Insider Sell: Santos da Silva Jorge Sells 102,225 Shares of MoonLake Immunotherapeutics (MLTX)
Related Stocks: MLTX
GuruFocus·3d ago
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good reason.
24/7 Wall St.·7d ago
Universal Music Repurchases $290.5 Million in Shares from Bill Ackman's Pershing Square After Rejected Takeover
Bill Ackman is poised to sell $290.5 million in stock back to Universal Music Group after a rejected takeover offer.
Variety·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.